Season's Greetings newsletter

This email contains pictures, if you don’t see them, view it online

In this newsletter:

-Season's Greetings
-CROIT partnership in Japan
-EMA & MCRT Anonymization Initiative

We sincerely hope that you enjoy this newsletter. Please forward this to your colleagues or friends that may be interested!



As the year comes to a close, we would like to take the opportunity to greet all our clients, colleagues and friends and wish you a happy holiday.

2017 has been a very exciting year for Innovion, where we have launched our website and the periodic newsletter.  We appreciate all your feedback and response and feel that this is a convenient way to keep in touch.

2017 was also the year that we have officially launched our CRO oversight and EudraCT service offers and we were overwhelmed by your response.  We have strengthened our relationship with existing customers and have welcomed many new clients who found their way to our expertise.  

We are eagerly looking forward to next year where we will be launching new service offerings and industry solutions and we are always curious about your thoughts and feedback.


Innovion is pleased to announce a new partnership with CAC Croit and Formedix to provide CDISC services and support for global drug submissions to regulatory authorities. Innovion's and Formedix extensive experience using CDISC to accelerate trials in the US and Europe  for FDA and EMA submissions combined with CAC Croit's knowledge of PMDA submissions in Japan will bring the benefits of CDISC standards to the Japanese market.

read more


pictureInnovion represented CDISC at the EMA Data Anonymization workshop. This workshop was a joint initiative between the EMA and MCRT (Multi-Regional Clinical Trials) to focus on anonymization as a key enabler for clinical data sharing. The scope of the workshop covered clinical trial data including individual patient level data and real-world data in the context of patient registries and individual cohort studies.

The ambition of this initiative is to create one accepted, global anonymization approach while advocating data sharing for all research.  Innovion supports the goal that all research data will eventually be made available to further enable research.

There was a strong consensus that using the CDISC data standards should be highly recommended for all clinical research.

read more
-CDISC Consultancy | CDISC standards implementation
-Outsourcing Support | Organizational Support
linkedin | contact us
You don’t want to receive our news anymore, please unsubscribe.